Puma Biotechnology News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

23.05.17	Increasing Flurry of FDA Orphan Drug Development Activity Fueling Uptick of Enthusiasm for Few Pharma Stocks (PR Newswire)
23.05.17	FDA Approves 1st Drug For GCA, Puma Leaps, Will SBPH Spring A Surprise? (RTTNews)
19.05.17	PUMA BIOTECHNOLOGY LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In Puma Biotechnology, Inc. To Contact The Firm (PR Newswire)
18.05.17	Gainers & Losers Of May 17: SNDX, PULM, PBYI, CNCE, XLRN... (RTTNews)
13.05.17	SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Puma Biotechnology, Inc. of Class Action Lawsuit and Upcoming Deadline - PBYI (PR Newswire)
11.05.17	SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Puma Biotechnology, Inc. (PBYI) and Lead Plaintiff Deadline: July 7, 2017 (PR Newswire)
05.05.17	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Puma Biotechnology, Inc. - PBYI (PR Newswire)
18.04.17	OMED Disappoints, PBYI Soars, AMAG Seeks Expanded Approval For Makena (RTTNews)
18.04.17	Gainers & Losers Of Apr.17: CBLI, INFI, PBYI, OMED, INCY... (RTTNews)
05.04.17	Biotech Stocks on Investors' Radar -- Puma Biotechnology, Regeneron Pharma, Calithera, and Lexicon Pharma (PR Newswire)
09.03.17	Gainers & Losers Of Mar.8: GBT, CYCC, GNMX, MGCD, TRVN... (RTTNews)
02.03.17	FDA Approves Odactra, JUNO Abandons Rocket, VRML Abuzz, No Tremors For NDRM (RTTNews)
24.02.17	Research Reports Coverage on Biotech Stocks -- Puma Biotechnology, Dipexium Pharma, BioCryst Pharma, and CTI BioPharma (PR Newswire)
06.01.17	Research Reports Initiation on Biotech Stocks -- Puma Biotechnology, Seattle Genetics, Advaxis, and BioCryst Pharma (PR Newswire)
20.12.16	CLVS Gets FDA Nod, PBYI Leaves Big Board, LOXO Hits All-time High, CNAT On Watch (RTTNews)
28.11.16	Research Reports Initiation on Biotech Stocks -- ImmunoGen, Puma Biotech, Arrowhead Pharma, and Intra-Cellular Therapies (PR Newswire)
21.09.16	MSTX Crashes On EPIC Data, MIRN Ditches MRX34, More Good News From SRPT (RTTNews)
22.07.16	Puma Leaps After Hours, FDA Delays Decision On Merck's Drug, ADMP Optimistic (RTTNews)
28.06.16	AKER Up On Aero-Med Deal, Allergy Under The Weather, RGLS Falls On Clinical Hold (RTTNews)
29.03.16	ALDR Gains As Pain Wanes, APRI Disappoints, PBYI's NDA Filing Delayed Yet Again (RTTNews)
30.11.15	Puma Biotechnology Provides Update from Meeting with European Medicines Agency (Businesswire)
26.09.15	Puma Biotechnology Presents Positive Results From Phase III Trial Of PB272 (RTTNews)
17.03.15	Our Stock Picks That Surged Past $100 (RTTNews)
11.03.15	SUPN Gets Attention, AST For The Long Haul, OCUL To File NDA In Q2, ZGNX Slumps (RTTNews)
15.12.14	CCXI Swells On Trial Data, PETM Taken Private, Genmab Gets Richer, Onus On ONTY (RTTNews)
03.12.14	MÄRKTE USA/Vorsichtiges Abwarten an der Wall Street (Dow Jones)
03.12.14	MARKT USA/Verschnaufpause nach Gipfelsturm (Dow Jones)
11.11.14	AMGN Gets FDA Date, TTPH On Track, SAGE Keeps Calm, Busy Months Ahead For XNCR (RTTNews)
10.11.14	Puma Biotechnology Loss Widens (RTTNews)
29.09.14	Puma Biotechnology Announces Initial Results From Phase 2 Trial For PB272 (RTTNews)
29.09.14	Puma Biotechnology Announces Positive Initial Results from PB272 Phase II Trial in HER2 Mutated Non-Small Cell Lung Cancer (Businesswire)
03.09.14	Puma Biotechnology Announces Late-Breaking Oral Presentation on Neratinib in NSCLC with HER2 Mutations at ESMO 2014 (Businesswire)
03.03.14	Puma Biotechnology Q4 Loss Narrows - Quick Facts (RTTNews)
18.12.13	Capricor On A Starry Start, Onconova's ONTRAC Out Of Track, PBYI On Watch (RTTNews)
06.12.13	BSDM Gets Business, BOTA's IGLOO Building Up, PBYI Leaps To New High (RTTNews)
05.12.13	ROUNDUP/Aktien New York Schluss: Leichter wegen geldpolitischer Sorgen (dpa-afx)
05.12.13	Aktien New York: Leichter vor wichtigem US-Arbeitsmarktbericht (dpa-afx)
05.12.13	ROUNDUP/Aktien New York: Leichter vor gespannt erwartetem Arbeitsmarktbericht (dpa-afx)
04.12.13	Puma Biotechnology Reveals Positive Data From I-SPY 2 TRIAL (RTTNews)
14.10.13	Trial Updates and Public Offering - Research Report on Gilead, Celgene, Ariad, Puma Biotechnology, and Dyax (PR Newswire)
07.10.13	ATOS Crushed, CVM Gets Grace Period, DSCO Soars, MNOV On The Watch (RTTNews)
04.10.13	Puma Begins Phase II Trial Of Neratinib In Solid Tumors With HER2 Mutation (RTTNews)
12.08.13	Public Offerings of Common Stock, Financial Results, and Significant Progress in Key Development Programs - Research Report on BioCryst, Exelixis, Idenix, Puma Biotechnology, and Halozyme (PR Newswire)
07.08.13	AVNR Nears PRIME Time, CRTX Turns The Corner, NSPH Falls Big, Busy Time For PBYI (RTTNews)
07.08.13	Puma Biotechnology Q2 Loss Narrows - Quick Facts (RTTNews)
02.06.12	Puma Biotechnology Presents Positive PB272 Clinical Data at ASCO 2012 Annual Meeting (Businesswire)
30.05.12	Puma Biotechnology to Present at Jefferies Healthcare Conference (Businesswire)
17.05.12	Puma Biotechnology to Present Clinical Data on PB272 at ASCO 2012 Annual Meeting (Businesswire)
09.05.12	Puma Biotechnology to Present at BofA Merrill Lynch Health Care Conference (Businesswire)
16.04.12	Puma Biotechnology Cleared for Quotation on OTCBB and OTC LINK (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’263.50	2.89 %	K V
Sonova Hldg	312.10	2.66 %	K V
Novartis	93.68	2.32 %	K V
Geberit	526.80	1.97 %	K V
Roche Hldg G	254.30	1.27 %	K V
Kuehne+Nagel Int	209.50	0.72 %	K V
UBS Group	28.30	0.57 %	K V
Givaudan	3’933.00	0.36 %	K V
Nestle	76.00	0.05 %	K V
Lonza Grp	521.40	-0.04 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Puma Biotechnology Inc

Aktien Top/Flop

Meistgelesene Nachrichten